ELEDON PHARMACEUTICALS INC's ticker is ELDN and the CUSIP is 28617K101. A total of 33 filers reported holding ELEDON PHARMACEUTICALS INC in Q2 2022. The put-call ratio across all filers is - and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $38,774 | 0.0% | 28,302 | 0.0% | 0.00% | – |
| Q2 2023 | $38,774 | -68.7% | 28,302 | -46.2% | 0.00% | – |
| Q1 2023 | $124,060 | +5.1% | 52,568 | +1.5% | 0.00% | – |
| Q4 2022 | $118,036 | -13.2% | 51,770 | +4.9% | 0.00% | – |
| Q3 2022 | $136,000 | +15.3% | 49,365 | +2.2% | 0.00% | – |
| Q2 2022 | $118,000 | -49.8% | 48,291 | -18.9% | 0.00% | – |
| Q1 2022 | $235,000 | -15.8% | 59,547 | -5.7% | 0.00% | – |
| Q4 2021 | $279,000 | -4.8% | 63,166 | +33.0% | 0.00% | – |
| Q3 2021 | $293,000 | -19.9% | 47,508 | +2.6% | 0.00% | – |
| Q2 2021 | $366,000 | +179.4% | 46,294 | +276.9% | 0.00% | – |
| Q1 2021 | $131,000 | – | 12,282 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Logos Global Management LP | 1,339,793 | $8,280,000 | 0.60% |
| CM Management, LLC | 75,000 | $464,000 | 0.35% |
| BVF INC/IL | 1,363,435 | $8,426,000 | 0.33% |
| Cormorant Asset Management, LP | 1,305,095 | $8,065,000 | 0.33% |
| Ikarian Capital, LLC | 344,578 | $2,129,000 | 0.15% |
| Woodline Partners LP | 781,376 | $4,829,000 | 0.08% |
| Eversept Partners, LP | 114,008 | $704,569 | 0.05% |
| INGALLS & SNYDER LLC | 51,149 | $316,000 | 0.01% |
| Virtu Financial LLC | 18,610 | $115,000 | 0.01% |
| BOOTHBAY FUND MANAGEMENT, LLC | 34,630 | $214,000 | 0.01% |